Eline D'Joos

Eline D'Joos


Eline focusses on regulatory issues and commercial transactions in the life science sector, as well as general intellectual property and data protection. She also has expertise in drafting and negotiating high value IP licenses, R&D collaborations and commercial agreements in the telecom and chemicals sectors.
She advises multinational companies and start-ups as well as research institutes in the pharmaceutical, biotech and medical devices sectors on a variety of complex matters, including clinical trials, product approvals, regulatory incentives, market access, biosimilars, orphan drugs, Belgian supplementary protection certificates and the regulatory approval pathway to bring vaccines to market. She has regularly assisted with mergers and acquisitions of life sciences companies, as well as patent infringement proceedings and preliminary injunctions in relation to strategic drugs.

Published Work

  • CARMELIET, T., D’JOOS, E., et al., (2022) ""Paediatric Medicines"", LexisNexis, Practice Note



Dutch, English
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.